R
Ricardo Seabra-Gomes
Researcher at Uppsala University Hospital
Publications - 56
Citations - 4146
Ricardo Seabra-Gomes is an academic researcher from Uppsala University Hospital. The author has contributed to research in topics: Myocardial infarction & Restenosis. The author has an hindex of 23, co-authored 56 publications receiving 4024 citations.
Papers
More filters
Journal ArticleDOI
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
Patrick W. Serruys,Ben A. van Hout,Hans Bonnier,Victor Legrand,Eulogio García,Carlos Macaya,Eduardo Sousa,Wim Der Van Giessen,Antonio Colombo,Ricardo Seabra-Gomes,Ferdinand Kiemeneij,Peter Ruygrok,John A. Ormiston,Håkan Emanuelsson,Jean Fajadet,Michael Haude,Silvio Klugmann,Marie Angèle Morel +17 more
TL;DR: Over 12-month follow-up, a strategy of elective stenting with heparin-coated stents is more effective but also more costly than balloon angioplasty.
Journal ArticleDOI
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
E.J. Topol,A.M. Lincoff,Robert M. Califf,Erik Magnus Ohman,Eric R. Bates,W.B. Gibler,Judith S. Hochman,Neal S. Kleiman,James T. Willerson,Liliana Grinfeld,P Alward,F. Van de Werf,Paul W. Armstrong,Juhani Heikkilä,A Vahanian,Gabriel Steg,Christoph Bode,Aaj Adgy,Guetta,Diego Ardissino,Stefano Savonitto,Frits W. Bär,M. L. Simoons,F Kontny,Harvey D. White,Zygmunt Sadowski,Ricardo Seabra-Gomes,Anthony J. Dalby,Amadeo Betriu,Eva Swahn,Robert G. Wilcox +30 more
TL;DR: Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrine therapy and platelet glycoprotein IIb/IIIa inhibition : the GUSTO V randomised trial.
Journal ArticleDOI
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial
Philip A. Poole-Wilson,Jacobus Lubsen,Bridget-Anne Kirwan,Fred J van Dalen,Gilbert Wagener,Nicolas Danchin,Hanjörg Just,Keith A.A. Fox,Stuart J. Pocock,Tim Clayton,Michael Motro,John D. Parker,Martial G. Bourassa,Anthony M. Dart,Per Hildebrandt,Åke Hjalmarson,Johannes A. Kragten,G Peter Molhoek,J.E. Otterstad,Ricardo Seabra-Gomes,Jordi Soler-Soler,Simon Weber +21 more
TL;DR: Addition of nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival and is safe and reduces the need for coronary angiography and interventions.
Journal ArticleDOI
TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS.
TL;DR: The RSs studied demonstrated a good predictive accuracy for death or MI at 1 year and enabled the identification of high-risk subsets of patients who will benefit most from myocardial revascularization performed during initial hospital stay.
Journal ArticleDOI
TIMI, PURSUIT, and GRACE Risk Scores: Sustained Prognostic Value and Interaction With Revascularization in NSTE-ACS
TL;DR: The RSs studied demonstrated a good predictive accuracy for death or MI at 1 year and enabled the identification of high-risk subsets of patients who will benefit most from myocardial revascularization performed during initial hospital stay.